The purpose of this study is to evaluate whether a novel decision support tool called PRIME (Preference Reporting to Improve Management and Experience), which combines values-elicitation with tailored feedback to patients and providers, improves patient-reported values-concordance of initial treatment decisions compared to usual care.
Hematologic Malignancies, Lymphoma, Multiple Myeloma, Leukemia, Blood Cancers
The purpose of this study is to evaluate whether a novel decision support tool called PRIME (Preference Reporting to Improve Management and Experience), which combines values-elicitation with tailored feedback to patients and providers, improves patient-reported values-concordance of initial treatment decisions compared to usual care.
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
-
Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill, North Carolina, United States, 27516
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
60 Years to
ALL
No
UNC Lineberger Comprehensive Cancer Center,
Daniel R Richardson, MD, MA, MSc, PRINCIPAL_INVESTIGATOR, UNC Lineberger Comprehensive Cancer Center
2028-09-01